🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
63.62
-1.36 (-2.09%)
Nov 20, 2026, 4:00 PM EST - Market closed

Corcept Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
162.2999.65141.21106.14101.42112.51
Depreciation & Amortization
2.971.891.342.363.453.48
Loss (Gain) From Sale of Investments
-3.36-5.1-10.94-9.131.38-
Stock-Based Compensation
102.6784.561.3548.9442.4442.93
Other Operating Activities
-15.8-37.54-40.19-29.49-33.919.44
Change in Accounts Receivable
-41.43-5.81-12.85-10.07-3.43-1.43
Change in Inventory
-12.11-7.480.311.271.23.44
Change in Accounts Payable
-12.5425.07-2.025.424.76-3.6
Change in Income Taxes
1.091.093.781.218.690.01
Change in Other Net Operating Assets
14.32-14.2856.3210.03-5.671.1
Operating Cash Flow
198.11142198.3126.68120.32167.89
Operating Cash Flow Growth
21.09%-28.39%56.53%5.28%-28.33%10.48%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.49-0.21-2.17-0.14-0.41-0.47
Investment in Securities
-165.0469.97-175.4391.05-113.91136.6
Investing Cash Flow
-168.5369.76-177.690.91-114.33136.13

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
41.0725.499.625.814.3816.23
Repurchase of Common Stock
-97.45-245.86-37.97-154.53-21.67-318.82
Financing Cash Flow
-56.38-220.37-28.35-148.72-17.28-302.59

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.21.44-0.230.36--
Net Cash Flow
-27-7.17-7.8969.22-11.291.43

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
194.62141.79196.12126.54119.91167.42
Free Cash Flow Growth
19.16%-27.71%54.99%5.53%-28.38%11.07%
Free Cash Flow Margin
20.20%18.62%29.05%26.23%29.84%45.75%
Free Cash Flow Per Share
1.631.181.731.131.031.33
Levered Free Cash Flow
132.18114.19183.85128.39115.55120.18
Unlevered Free Cash Flow
132.18114.19183.85128.39115.55120.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
12.9712.9760.2747.639.759.1
Change in Working Capital
-50.67-1.4145.537.865.54-0.47
SEC Filings: 10-K · 10-Q